Rigel Pharmaceuticals
The Institutional Business Manager drives adoption and sales performance for Rigel's Hematology & Solid Tumor oncology portfolio across key institutional and health system accounts. This role involves developing strategic account plans, understanding customer needs, and delivering clinical and business value to healthcare providers and decision-makers. The position requires navigating complex healthcare systems while maintaining compliance and achieving territory objectives.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
1996
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company markets approved products including TAVALISSE, REZLIDHIA, and Gavreto, and maintains a pipeline of clinical programs including IRAK1/4 and RIPK1 inhibitors. Rigel is publicly traded under the ticker RIGL and is headquartered in South San Francisco, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rigel Pharmaceuticals.
88% above the average for this role
Territory Manager, Breast Cancer/Solid Tumor
Cascadia Search Group
Assistant/Associate/Full Professor of Clinical, Division of Hematology & Oncology, Solid Tumor
City of Pembroke Pines
Institutional Sales Representative
Novartis
Division Sales Manager
BeOne Medicines
Senior Field Medical Director – Florida/PR
BeOne Medicines
Hematology Oncology Physician Assistant
Lehigh Valley Health Network